Vorsorgeuntersuchungen und Check-ups in der Kardiologie

Abstract

Cardiovascular diseases (CVD), especially coronary artery disease (CAD), are the leading causes of morbidity and mortality worldwide. Elimination of modifiable risk factors has the potential to prevent up to 80 % of CVD. Therefore, disease prevention is based on the assessment of individual total CVD risk by using risk scores such as SCORE-algorithm that include the known main cardiovascular risk factors such as age, sex, smoking status, arterial hypertension und cholesterol.

Kardiovaskuläre Erkrankungen (CVD) sind weltweit die wichtigsten Erkrankungs- und Todesursachen [1]. Die chronische KHK zum Beispiel hat eine lange asymptomatische Latenzphase und eignet sich für frühe präventive Interventionen. Hochrechnungen zufolge könnte die Kontrolle der Risikofaktoren bis zu 80 % der kardiovaskulären Erkrankungslast reduzieren [2] [3]. Daher ist es wichtig, Erkrankungsrisiken frühzeitig zu erkennen und zu beeinflussen.

Schlüsselwörter

kardiovaskuläres Risiko - nichtinvasive kardiologische Diagnostik - nichtsymptomatische Personen - bildgebende Diagnostik - Prävention kardiovaskulärer Erkrankungen

Key words

cardiovascular risk assessment - non-invasive cardiologic investigations - asymptomatic persons - non-invasive imaging - prevention of cardiovascular diseases

• Literatur

• 1 WHO. Global Health Estimates 2016: Disease burden by Cause, Age, Sex, by Country and by Region, 2000–2016. Geneva: WHO; 2018 Im Internet: www.who.int/healthinfo/global_burden_disease ; Stand: 28.06.2019
• 2 Piepoli MF, Hoes AW, Agewall S. et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2016; 37 (29) 2315-2381 . doi:10.1093/eurheartj/ehw106
• 3 Laufs U, Ference BA. Vaccination to prevent atherosclerotic cardiovascular diseases. Eur Heart J 2017; 38 (32) 2508-2510 . doi:10.1093/eurheartj/ehx302
• 4 Greenland P, Knoll MD, Stamler J. et al. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA 2003; 290 (07) 891-897 . doi:10.1001/jama.290.7.891
• 5 Ludt S, Angelow A, Baum E. et al. Hausärztliche Risikoberatung zur kardiovaskulären Prävention. S3-Leitlinie. AWMF-Register-Nr. 053-024. Hamburg, Berlin: Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin e.V; 2018
• 6 Bundesärztekammer, Kassenärztliche Bundesvereinigung, Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. Nationale VersorgungsLeitlinie Chronische KHK – Langfassung. 5.. Aufl. Berlin: Ärztliches Zentrum für Qualität in der Medizin; 2019.
• 7 Montalescot G, Sechtem U, Achenbach S. et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013; 34 (38) 2949-3003 . doi:10.1093/eurheartj/eht296
• 8 Grammer TB, Dressel A, Gergei I. et al. Cardiovascular risk algorithms in primary care: Results from the DETECT study. Sci Rep 2019; 9 (01) 1101 . doi:10.1038/s41598-018-37092-7
• 9 Grundy SM, Stone NJ, Bailey AL. et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol. Circulation 2019; 139: e1082-e1143 . doi:10.1161/CIR.0000000000000625
• 10 Williams B, Mancia G, Spiering W. et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J 2018; 39 (33) 3021-3104 . doi:10.1093/eurheartj/ehy339
• 11 Osiro S, Zurada A, Gielecki J. et al. A review of subclavian steal syndrome with clinical correlation. Med Sci Monit 2012; 18 (05) RA57-RA63 . doi:10.12659/MSM.882721
• 12 Mathes T, Thomas S. EKG zur Früherkennung einer koronaren Herzerkrankung – Evidenz ausführlich. Essen: Medizinischer Dienst des Spitzenverbandes Bund der Krankenkassen e. V. (MDS); 2017
• 13 Maron BJ, Friedman RA, Kligfield P. et al. Assessment of the 12-lead ECG as a screening test for detection of cardiovascular disease in healthy general populations of young people (12–25 Years of Age): a scientific statement from the American Heart Association and the American College of Cardiology. Circulation 2014; 130 (15) 1303-1334 . doi:10.1161/CIR.0000000000000025
• 14 Pais P. Treadmill stress tests should not be part of “routine health check package”. Indian Heart J 2018; 70 (06) 934-936 . doi:10.1016/j.ihj.2018.09.010
• 15 Lawall H, Huppert P, Rümenapf G. S3-Leitlinie zur Diagnostik, Therapie und Nachsorge der peripheren arteriellen Verschlusskrankheit. AWMF-Register Nr. 065/003. Berlin: Deutsche Gesellschaft für Angiologie – Gesellschaft für Gefäßmedizin e.V; 2015
• 16 American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2019. Diabetes Care 2019; 42: S13-S28 . doi:10.2337/dc19-S002
• 17 Perkovic V, Verdon C, Ninomiya T. et al. The relationship between proteinuria and coronary risk: a systematic review and meta-analysis. PLoS Med 2008; 5 (10) e207 . doi:10.1371/journal.pmed.0050207
• 18 Sarraju A, Knowles JW. Genetic Testing and Risk Scores: Impact on Familial Hypercholesterolemia. Front Cardiovasc Med 2019; 6: 5 . doi:10.3389/fcvm.2019.00005
• 19 Senior R, Becher H, Monaghan M. et al. Clinical practice of contrast echocardiography: recommendation by the European Association of Cardiovascular Imaging (EACVI) 2017. Eur Heart J Cardiovasc Imaging 2017; 18 (11) 1205-1205 af . doi:10.1093/ehjci/jex182
• 20 Newby DE, Adamson PD, Berry C. et al. Coronary CT Angiography and 5-Year Risk of Myocardial Infarction. N Engl J Med 2018; 379 (10) 924-933 . doi:10.1056/NEJMoa1805971